{
    "medicine_id": "47b7c2d3ee6964e89bf90cce9153ad72651889f1",
    "platform_id": "DB09082",
    "metadata": {
        "name": "Anoro 55 \u00b5g Powder",
        "composition": "55 \u00b5g Vilanterol",
        "clinical_particulars": {
            "therapeutic_indications": "Vilanterol is approved for use in several combination products such as with fluticasone furoate under the tradename Breo Ellipta and in combination with umeclidinium bromide as Anoro Ellipta Approved by the FDA in 2013 use of Breo Ellipta is indicated for the long term once daily maintenance treatment of airflow obstruction in patients with COPD including chronic bronchitis and emphysema It is also indicated for once daily maintenance treatment of asthma in patients aged 18 or older with reversible obstructive airways disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n1 is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2b is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Interferon gamma 1b is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Interferon beta 1b is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Alefacept is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Efalizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2b is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Daclizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Bevacizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of adverse effects can be increased when Flunisolide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of adverse effects can be increased when Bortezomib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Cladribine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Carmustine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Amsacrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Bleomycin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Raltitrexed is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Mitomycin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of adverse effects can be increased when Bexarotene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of adverse effects can be increased when Vindesine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Floxuridine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Indomethacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Tioguanine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of adverse effects can be increased when Sorafenib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Streptozocin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Trifluridine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of adverse effects can be increased when Betamethasone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of adverse effects can be increased when Teniposide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Lenalidomide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Altretamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Zidovudine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Cisplatin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of adverse effects can be increased when Vincristine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Fluorouracil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Pentostatin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of adverse effects can be increased when Methotrexate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of adverse effects can be increased when Vinblastine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of adverse effects can be increased when Imatinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of adverse effects can be increased when Triamcinolone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Prednisone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Pemetrexed is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of adverse effects can be increased when Daunorubicin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of adverse effects can be increased when Irinotecan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The risk or severity of adverse effects can be increased when Methimazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of adverse effects can be increased when Etoposide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Dacarbazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Temozolomide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Penicillamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of adverse effects can be increased when Prednisolone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Azacitidine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Carboplatin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Dactinomycin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Cytarabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Azathioprine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of adverse effects can be increased when Doxorubicin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of adverse effects can be increased when Topotecan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Thalidomide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Melphalan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Fludarabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Flucytosine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Capecitabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Trilostane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Idarubicin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of adverse effects can be increased when Ifosfamide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Estramustine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Lomustine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of adverse effects can be increased when Docetaxel is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Eculizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Decitabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of adverse effects can be increased when Sunitinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Nelarabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of adverse effects can be increased when Corticotropin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of adverse effects can be increased when Paramethasone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Ciclesonide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Stepronin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Castanospermine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Vorinostat is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when 2 Methoxyethanol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Brequinar is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of adverse effects can be increased when Thiotepa is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Aldosterone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of adverse effects can be increased when Ixabepilone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of adverse effects can be increased when Nilotinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Pirfenidone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Belinostat is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of adverse effects can be increased when Trabectedin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Briakinumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Human interferon omega 1 is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of adverse effects can be increased when Pazopanib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of adverse effects can be increased when Panobinostat is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Mepolizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of adverse effects can be increased when Bosutinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Abetimus is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Belatacept is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Bendamustine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Pralatrexate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Wortmannin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Eribulin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Belimumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The risk or severity of adverse effects can be increased when Teriflunomide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of adverse effects can be increased when Carfilzomib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of adverse effects can be increased when Ponatinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of adverse effects can be increased when Fluprednidene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Vedolizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Blinatumomab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The risk or severity of adverse effects can be increased when Idelalisib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of adverse effects can be increased when Palbociclib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of adverse effects can be increased when Olaparib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Dinutuximab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Ocrelizumab"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Epirubicin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of adverse effects can be increased when Budesonide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The risk or severity of adverse effects can be increased when Etanercept is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The risk or severity of adverse effects can be increased when Anakinra is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Adalimumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Infliximab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of adverse effects can be increased when Sirolimus is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of adverse effects can be increased when Busulfan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Paclitaxel is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of adverse effects can be increased when Dasatinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The risk or severity of adverse effects can be increased when Abatacept is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of adverse effects can be increased when Colchicine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of adverse effects can be increased when Everolimus is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Afelimomab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The risk or severity of adverse effects can be increased when Apremilast is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Canakinumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Tocilizumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of adverse effects can be increased when Temsirolimus is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The risk or severity of adverse effects can be increased when Rilonacept is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when Golimumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when Secukinumab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when Siltuximab is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of adverse effects can be increased when Ibrutinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of adverse effects can be increased when Fluocinonide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Desoximetasone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of adverse effects can be increased when Mometasone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of adverse effects can be increased when Fluocortolone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Vilanterol may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Vilanterol may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Vilanterol may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Vilanterol may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Vilanterol may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Vilanterol may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Vilanterol may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Vilanterol may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Vilanterol may decrease the antihypertensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Vilanterol may decrease the antihypertensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Vilanterol may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Vilanterol may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Vilanterol may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Vilanterol may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Vilanterol may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Vilanterol may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Vilanterol may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Vilanterol may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Vilanterol may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Vilanterol may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Vilanterol may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Vilanterol may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Vilanterol may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Vilanterol may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Vilanterol may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Vilanterol may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Vilanterol may decrease the antihypertensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Vilanterol may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Vilanterol may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Vilanterol may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Vilanterol may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Vilanterol may decrease the antihypertensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Vilanterol may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Vilanterol may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Vilanterol may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Vilanterol may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Vilanterol may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Vilanterol may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Vilanterol may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Vilanterol may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Vilanterol may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Vilanterol may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Vilanterol may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Vilanterol may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Vilanterol may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Vilanterol may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Vilanterol may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Vilanterol may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Vilanterol may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Vilanterol may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Vilanterol may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Vilanterol may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Vilanterol may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Vilanterol may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Vilanterol may decrease the antihypertensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Vilanterol may decrease the antihypertensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "Vilanterol may decrease the antihypertensive activities of Clonidine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Vilanterol may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Vilanterol may decrease the antihypertensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Vilanterol may decrease the antihypertensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Vilanterol may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Vilanterol may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Vilanterol may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Vilanterol may decrease the antihypertensive activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Vilanterol may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Vilanterol may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Vilanterol may decrease the antihypertensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Vilanterol may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Vilanterol may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of hypertension can be increased when Midodrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of hypertension can be increased when Bethanidine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of hypertension can be increased when Zolmitriptan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypertension can be increased when Phenylephrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of hypertension can be increased when Metaraminol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of hypertension can be increased when Guanabenz is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of hypertension can be increased when Methoxamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of hypertension can be increased when Remifentanil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of hypertension can be increased when Diethylpropion is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of hypertension can be increased when Naratriptan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of hypertension can be increased when Frovatriptan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Rescinnamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of hypertension can be increased when Ephedrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of hypertension can be increased when Mephentermine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of hypertension can be increased when MMDA is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of hypertension can be increased when Midomafetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of hypertension can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of hypertension can be increased when 4 Methoxyamphetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of hypertension can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of hypertension can be increased when Tenamfetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of hypertension can be increased when Chlorphentermine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of hypertension can be increased when Phendimetrazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of hypertension can be increased when Amibegron is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of hypertension can be increased when Naluzotan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of hypertension can be increased when Solabegron is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of hypertension can be increased when Esmirtazapine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of hypertension can be increased when Nitrous oxide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypertension can be increased when Xylometazoline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of hypertension can be increased when Isometheptene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypertension can be increased when Levonordefrin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypertension can be increased when Naphazoline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Saralasin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of hypertension can be increased when Tetryzoline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of hypertension can be increased when Cinitapride is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Tyramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of hypertension can be increased when Adrafinil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of hypertension can be increased when Isoxsuprine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of hypertension can be increased when Ifenprodil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of hypertension can be increased when Etilefrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Atipamezole"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Theodrenaline"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dutasteride is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of hypertension can be increased when Phentermine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of hypertension can be increased when Eletriptan is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of hypertension can be increased when Sufentanil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of hypertension can be increased when Tranylcypromine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of hypertension can be increased when Alfentanil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of hypertension can be increased when Benzphetamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of hypertension can be increased when Methoxyflurane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of hypertension can be increased when Selegiline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of hypertension can be increased when Halothane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Finasteride is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of hypertension can be increased when Yohimbine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of hypertension can be increased when Flibanserin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of hypertension can be increased when Rotigotine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of hypertension can be increased when Cariprazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of hypertension can be increased when Mianserin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypertension can be increased when Nylidrin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of hypertension can be increased when Safinamide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of hypertension can be increased when Vilazodone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of hypertension can be increased when Fentanyl is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Vilanterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone phosphate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone hemisuccinate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisone acetate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The risk or severity of hypokalemia can be increased when Clocortolone acetate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The risk or severity of hypokalemia can be increased when Melengestrol acetate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The risk or severity of hypokalemia can be increased when Cortisone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Atomoxetine may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09059",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Atosiban"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Betahistine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Vilanterol may increase the immunosuppressive activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Vilanterol may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Cabergoline may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Lisuride may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Pergolide may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergometrine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Ergotamine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Bromocriptine may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "Duloxetine may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "Levomilnacipran may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may increase the tachycardic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Alfuzosin"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Prazosin"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Terazosin"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Silodosin"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Indoramin"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB12230",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bunazosin"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Propiverine"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Urapidil"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of hypertension can be increased when Protriptyline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of hypertension can be increased when Amoxapine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of hypertension can be increased when Amineptine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of hypertension can be increased when Dosulepin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of hypertension can be increased when Oxaprotiline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of hypertension can be increased when Opipramol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of hypertension can be increased when Dibenzepin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of hypertension can be increased when Quinupramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of hypertension can be increased when Melitracen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of hypertension can be increased when Lofepramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of hypertension can be increased when Iprindole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of hypertension can be increased when Imipramine oxide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of hypertension can be increased when Vilanterol is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of hypertension can be increased when Desipramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of hypertension can be increased when Clomipramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of hypertension can be increased when Dimetacrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Sotalol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Propranolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Oxprenolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "Bopindolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Cloranolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "Mepindolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Tertatolol may decrease the bronchodilatory activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Imipramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of hypokalemia can be increased when Vilanterol is combined with Piretanide"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of hypokalemia can be increased when Vilanterol is combined with Azosemide"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of hypokalemia can be increased when Etacrynic acid is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of hypokalemia can be increased when Furosemide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of hypokalemia can be increased when Bumetanide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of hypokalemia can be increased when Torasemide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Clorgiline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Iproniazid is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nialamide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Hydracarbazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Benmoxin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Mebanazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Octamoxin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Pheniprazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Pivhydrazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Safrazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Caroxazone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Harmaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Brofaromine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of adverse effects can be increased when Isoetharine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of adverse effects can be increased when Norepinephrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of adverse effects can be increased when Epinephrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of adverse effects can be increased when Orciprenaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of adverse effects can be increased when Dobutamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of adverse effects can be increased when Ritodrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of adverse effects can be increased when Terbutaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of adverse effects can be increased when Bitolterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of adverse effects can be increased when Salmeterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of adverse effects can be increased when Salbutamol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of adverse effects can be increased when Isoprenaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of adverse effects can be increased when Arbutamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of adverse effects can be increased when Arformoterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Fenoterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of adverse effects can be increased when Pirbuterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of adverse effects can be increased when Ephedra sinica root is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of adverse effects can be increased when Procaterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of adverse effects can be increased when Clenbuterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of adverse effects can be increased when Bambuterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of adverse effects can be increased when Droxidopa is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of adverse effects can be increased when Protokylol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of adverse effects can be increased when Olodaterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Batefenterol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of adverse effects can be increased when Vilanterol is combined with Doxofylline"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Vilanterol may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Vilanterol can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Esmolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Practolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Nebivolol"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bufuralol"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Indenolol"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Arotinolol"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Levobetaxolol"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bucindolol"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Epanolol"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The therapeutic efficacy of Landiolol can be decreased when used in combination with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Celecoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "Givosiran may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Vilanterol may decrease the excretion rate of Loxoprofen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Fluvoxamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "Tramadol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "Ticlopidine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Doxycycline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Topiramate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Acetaminophen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Hydromorphone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Clobazam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Rosiglitazone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Nitric Oxide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Fosinopril may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Methoxsalen may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lisinopril may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Thiabendazole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Nateglinide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Propantheline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Perindopril may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Dicyclomine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Isoniazid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Metyrapone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Probenecid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Fenofibrate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Dimethyl sulfoxide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tolbutamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tiludronic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Doxacurium may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Flavoxate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Bupropion may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Gemfibrozil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Iodixanol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Sitagliptin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Varenicline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Hydralazine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Tiotropium may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Amrinone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Oxybenzone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Fenproporex may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Bromazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Ketazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Valganciclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Sorbitol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Lorcaserin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Pegaptanib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Clevidipine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Migalastat may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Pentaerythritol tetranitrate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Ipilimumab may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Icatibant may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Alogliptin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Prasugrel may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Doripenem may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Nalmefene may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Saxagliptin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Prucalopride may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Flupirtine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Dalfampridine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Fesoterodine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Gadofosveset trisodium may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Methyltestosterone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Ammonium chloride may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Mangafodipir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Methylnaltrexone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Plerixafor may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tiopronin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Triethylenetetramine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Ioflupane I 123 may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Deferiprone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "N methylnicotinamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Peginesatide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Aclidinium may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Teduglutide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Formestane may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Glycerol phenylbutyrate may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Trametinib may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Macitentan may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Sofosbuvir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Ledipasvir may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Ceftolozane may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Corifollitropin alfa may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Vortioxetine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Tasimelteon may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "Edoxaban may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Idebenone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Vilanterol may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Vilanterol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Vilanterol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Vilanterol may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Vilanterol may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Vilanterol may decrease the excretion rate of Dienogest which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Vilanterol may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Vilanterol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Vilanterol may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Vilanterol may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Vilanterol may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Vilanterol may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Vilanterol may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Vilanterol may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Vilanterol may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Vilanterol may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Vilanterol may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Vilanterol may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Vilanterol may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Vilanterol may decrease the excretion rate of Viloxazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Vilanterol may decrease the excretion rate of Etoperidone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Vilanterol may decrease the excretion rate of Lorpiprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Vilanterol may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Vilanterol may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Vilanterol may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Vilanterol may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Vilanterol may decrease the excretion rate of Nicorandil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Vilanterol may decrease the excretion rate of Blonanserin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Vilanterol may decrease the excretion rate of Methylene blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Vilanterol may decrease the excretion rate of Pirlindole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Vilanterol may decrease the excretion rate of Toloxatone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Vilanterol may decrease the excretion rate of Dextran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Vilanterol may decrease the excretion rate of Tegafur which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Vilanterol may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Vilanterol may decrease the excretion rate of Imidafenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Vilanterol may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Vilanterol may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Vilanterol may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Vilanterol may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Vilanterol may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Vilanterol may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Vilanterol may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Vilanterol may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Vilanterol may decrease the excretion rate of Synthetic Conjugated Estrogens A which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Vilanterol may decrease the excretion rate of Synthetic Conjugated Estrogens B which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Vilanterol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Vilanterol may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Vilanterol may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Vilanterol may decrease the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Vilanterol may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Vilanterol may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Vilanterol may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Vilanterol may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Vilanterol may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Vilanterol may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Vilanterol may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Vilanterol may decrease the excretion rate of Enalaprilat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Vilanterol may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Vilanterol may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Vilanterol may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Vilanterol may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Vilanterol may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Vilanterol may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Vilanterol may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Vilanterol may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Vilanterol may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Vilanterol may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Vilanterol may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "Vilanterol may decrease the excretion rate of Opium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Vilanterol may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Vilanterol may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Vilanterol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Vilanterol may decrease the excretion rate of Pyrantel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Vilanterol may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Vilanterol may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Vilanterol may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Vilanterol may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Vilanterol may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Vilanterol may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Vilanterol may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Vilanterol may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Vilanterol may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Vilanterol may decrease the excretion rate of Antithrombin III human which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Vilanterol may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Vilanterol may decrease the excretion rate of Tropisetron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Vilanterol may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Vilanterol may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Vilanterol may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Vilanterol may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Vilanterol may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Vilanterol may decrease the excretion rate of Tiapride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Vilanterol may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Vilanterol may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Vilanterol may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Vilanterol may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Vilanterol may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Vilanterol may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Vilanterol may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Vilanterol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Vilanterol may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Vilanterol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Vilanterol may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Vilanterol may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Vilanterol may decrease the excretion rate of Estradiol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Vilanterol may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Vilanterol may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Vilanterol may decrease the excretion rate of Estradiol valerate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Vilanterol may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Vilanterol may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Vilanterol may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Vilanterol may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Vilanterol may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Vilanterol may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Vilanterol may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Vilanterol may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Vilanterol may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Vilanterol may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Pyrithione may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Vilanterol may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Vilanterol may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Vilanterol may decrease the excretion rate of Nisoldipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Vilanterol may decrease the excretion rate of Tadalafil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Alprazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Midazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Triazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Naloxone may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Rivaroxaban may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Enzalutamide may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Vilanterol may decrease the excretion rate of Stiripentol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Vilanterol may decrease the excretion rate of Apalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Vilanterol may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Codeine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Meperidine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Vilanterol may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Vilanterol may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Bepotastine may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Permethrin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Vilanterol may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Vilanterol may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Vilanterol may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Vilanterol may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Vilanterol may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Vilanterol may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Vilanterol may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Vilanterol may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Warfarin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Vilanterol may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Vilanterol may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Vilanterol may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Vilanterol may increase the excretion rate of Benzthiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Vilanterol may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Vilanterol may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Vilanterol may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Vilanterol may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Vilanterol may increase the excretion rate of Quinethazone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Vilanterol may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Vilanterol may increase the excretion rate of Epitizide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Vilanterol may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Indapamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Canagliflozin may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Vilanterol may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Vilanterol may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Vilanterol may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Vilanterol can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Profenamine"
                    },
                    {
                        "drugbank-id": "DB12057",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with ORM 12741"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of Tachycardia can be increased when Trospium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of Tachycardia can be increased when Ipratropium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of Tachycardia can be increased when Metixene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of Tachycardia can be increased when Procyclidine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of Tachycardia can be increased when Nabilone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of Tachycardia can be increased when Tridihexethyl is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of Tachycardia can be increased when Triflupromazine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of Tachycardia can be increased when Anisotropine methylbromide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of Tachycardia can be increased when Pirenzepine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of Tachycardia can be increased when Rocuronium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of Tachycardia can be increased when Scopolamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of Tachycardia can be increased when Benzquinamide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of Tachycardia can be increased when Clidinium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of Tachycardia can be increased when Biperiden is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of Tachycardia can be increased when Methantheline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of Tachycardia can be increased when Cycrimine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of Tachycardia can be increased when Mivacurium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of Tachycardia can be increased when Diphenidol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of Tachycardia can be increased when Metocurine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of Tachycardia can be increased when Pancuronium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of Tachycardia can be increased when Isopropamide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of Tachycardia can be increased when SLV319 is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of Tachycardia can be increased when Dimetindene is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of Tachycardia can be increased when Dexetimide is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of Tachycardia can be increased when Benactyzine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with GW842166"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Ajulemic acid"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Ibipinabant"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Surinabant"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Timepidium"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Palmidrol"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of Tachycardia can be increased when Nicotine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "The risk or severity of Tachycardia can be increased when Dronabinol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of Tachycardia can be increased when Darifenacin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of Tachycardia can be increased when Paroxetine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of Tachycardia can be increased when Rimonabant is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of Tachycardia can be increased when Vilanterol is combined with Nabiximols"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of Tachycardia can be increased when Chlorphenoxamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Vilanterol may increase the immunosuppressive activities of Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Vilanterol can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Formoterol may increase the sympathomimetic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Vilanterol can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Vilanterol can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Vilanterol is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Vilanterol can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Vilanterol can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}